Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Equity Ratio (2016 - 2025)

Aptevo Therapeutics (APVO) has disclosed Equity Ratio for 11 consecutive years, with 0.64 as the latest value for Q3 2025.

  • Quarterly Equity Ratio rose 120.76% to 0.64 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.64 through Sep 2025, up 120.76% year-over-year, with the annual reading at 0.3 for FY2024, 38.01% down from the prior year.
  • Equity Ratio hit 0.64 in Q3 2025 for Aptevo Therapeutics, up from 0.42 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.67 in Q1 2023 to a low of 0.18 in Q1 2025.
  • Historically, Equity Ratio has averaged 0.33 across 5 years, with a median of 0.35 in 2024.
  • Biggest YoY gain for Equity Ratio was 2345.22% in 2022; the steepest drop was 185.24% in 2022.
  • Year by year, Equity Ratio stood at 0.02 in 2021, then surged by 2345.22% to 0.53 in 2022, then decreased by 6.35% to 0.49 in 2023, then plummeted by 38.01% to 0.3 in 2024, then surged by 111.24% to 0.64 in 2025.
  • Business Quant data shows Equity Ratio for APVO at 0.64 in Q3 2025, 0.42 in Q2 2025, and 0.18 in Q1 2025.